HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children.

AbstractBACKGROUND:
Monocyte chemotactic protein 1 (MCP-1) plays an important role in various immune and allergic disorders since it is a potent chemo-attractant for inflammatory cells, such as eosinophils, memory T cells, and monocytes.
OBJECTIVE:
To investigate serum MCP-1 during asymptomatic state and acute attacks of bronchial asthma.
METHODS:
In this longitudinal cohort design study, sequential serum levels of MCP-1 were measured by a sandwich enzyme-linked immunosorbent assay (ELISA). Twenty-four asthma patients' MCP-1 levels were examined at 5 time points: during the asymptomatic phase, in an acute wheezing episode, and at 1 week, 1 month, and 2 months after acute asthma attack. Fifteen children without asthma were enrolled as control.
RESULTS:
During the asymptomatic phase of asthma, serum MCP-1 levels were significantly higher than that of normal controls (329.57 +/- 99.20 pg/ml vs. 213.63 +/- 77.29 pg/ml, p = 0.001). In comparison with the asymptomatic phase, the serum MCP-1 levels during the acute asthma attack were significantly higher (682.88 +/- 88.45 pg/ml vs. 329.57 +/- 99.20 pg/ml, p < 0.001). After treatment of acute asthma exacerbation, all of the serum MCP-1 levels declined within 1 week, but were still higher than control 2 months later.
CONCLUSION:
In asthma patients, the consistently elevated serum levels of MCP-1 suggest its role in the pathogenesis of bronchial asthma - not only in the chronic inflammatory processes, but also in acute asthma attack exacerbation. These findings suggest a possible role for MCP-1 in the pathogenesis of asthma and a potential role for its use in anti-asthma treatment in the future.
AuthorsChin-Kan Chan, Ming-Ling Kuo, Kuo-Wei Yeh, Liang-Shiou Ou, Li-Chen Chen, Tsung-Chieh Yao, Jing-Long Huang
JournalThe Journal of asthma : official journal of the Association for the Care of Asthma (J Asthma) Vol. 46 Issue 3 Pg. 225-8 (Apr 2009) ISSN: 1532-4303 [Electronic] England
PMID19373627 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androstadienes
  • Bronchodilator Agents
  • Chemokine CCL2
  • Fluticasone
  • Terbutaline
Topics
  • Acute Disease
  • Adolescent
  • Androstadienes (therapeutic use)
  • Asthma (blood, drug therapy)
  • Bronchodilator Agents (therapeutic use)
  • Chemokine CCL2 (biosynthesis, blood)
  • Child
  • China
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluticasone
  • Humans
  • Longitudinal Studies
  • Male
  • Respiratory Function Tests
  • Terbutaline (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: